SCHEMBL4149

SCHEMBL4149

COC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C

nearest known ligand 0.76

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 15/20 0.76
PGR P06401 6/20 0.76
HIF1A Q16665 3/20 0.76
NR1I2 O75469 2/20 0.76
LMNA P02545 1/20 0.76
CNR1 P21554 1/20 0.76
HSD17B10 Q99714 2/20 0.56
ABCB11 O95342 2/20 0.56
CYP3A4 P08684 1/20 0.56
TNF P01375 1/20 0.56
IL6 P05231 1/20 0.56
SERPINA6 P08185 1/20 0.56
NR3C2 P08235 1/20 0.56
AR P10275 1/20 0.56
GLUL P15104 1/20 0.56
ADAM17 P78536 1/20 0.56
GPBAR1 Q8TDU6 1/20 0.56
CYP2C19 P33261 1/20 0.56
ABCC3 O15438 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rimexolone SCHEMBL19327140 0.94 NR3C1 (0.88) NR3C1PGRHIF1ANR1I2LMNA
Prednylidene SCHEMBL6257149 0.87 NR3C1 (0.66) NR3C1PGRHIF1ANR1I2LMNA
Rimexolone SCHEMBL445300 0.86 NR3C1 (1.00) NR3C1PGRHIF1ANR1I2LMNA
Rimexolone SCHEMBL3062722 0.86 NR3C1 (1.00) NR3C1PGRHIF1ANR1I2LMNA
Rimexolone SCHEMBL29030108 0.86 NR3C1 (1.00) NR3C1PGRHIF1ANR1I2LMNA
SCHEMBL9470890 0.86 NR3C1 (0.86) NR3C1PGRHIF1ANR1I2LMNA
Rimexolone SCHEMBL13693339 0.86 NR3C1 (1.00) NR3C1PGRHIF1ANR1I2LMNA
SCHEMBL9470879 0.86 NR3C1 (0.86) NR3C1PGRHIF1ANR1I2LMNA
Rimexolone SCHEMBL29030109 0.86 NR3C1 (1.00) NR3C1PGRHIF1ANR1I2LMNA
Rimexolone SCHEMBL1651214 0.86 NR3C1 (1.00) NR3C1PGRHIF1ANR1I2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 15277 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260137656-A1 METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS SPARROW PHARMACEUTICALS INC (US) 2026-05-21 US claimed
US-20260137558-A1 OPHTHALMIC DEVICE Able Tx Ltd. (IL) 2026-05-21 US claimed
US-20260137657-A1 METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS SPARROW PHARMACEUTICALS INC (US) 2026-05-21 US claimed
WO-2026100654-A1 NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD 株式会社インファーマシア 2026-05-15 WO claimed
EP-4724079-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION Stealth BioTherapeutics Inc. (US) 2026-04-15 EP claimed
US-12569451-B2 Bio-inspired tissue-adhesive hydrogel patch and uses thereof Cellartgen Inc. (KR) 2026-03-10 US claimed
US-20260048096-A1 METHODS AND COMPOSITIONS FOR PRESERVING THE RETINAL OUTER NUCLEAR LAYER (ONL), PHOTORECEPTORS, AND RETINAL THICKNESS STEALTH BIOTHERAPEUTICS INC. (US) 2026-02-19 US claimed
US-20260034056-A1 PHARMACEUTICAL COMPOSITIONS FOR TREATING OCULAR DISEASES OR DISORDERS ALCON INC (CH) 2026-02-05 US claimed
EP-4683679-A1 METHOD FOR DIAGNOSING AND TREATING NIS-EXPRESSING CARCINOMAS AND METASTASES NUSKE, Andreas (DE) 2026-01-28 EP claimed
EP-4301343-B1 PHARMACEUTICAL COMPOSITIONS WITH REDUCED SIDE EFFECT AND METHODS OF USING THE SAME TLC BIOPHARMACEUTICALS INC (US) 2025-11-19 EP claimed
EP-0929565-A2 NITRATE ESTERS OF CORTICOID COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF NICOX S.A. (FR) 1999-07-21 EP claimed
WO-1998055126-A2 USE OF ANTI-INFLAMMATORY STEROIDS FOR THE TREATMENT OF CHRONIC INFLAMMATORY INTESTINAL DISEASES AKZO NOBEL N.V. (NL) 1998-12-10 WO claimed
WO-1998043630-A1 MEANS OF ASCERTAINING AN INDIVIDUAL'S RISK PROFILE FOR ATHEROSCLEROTIC DISEASE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 1998-10-08 WO claimed
WO-1998029069-A2 METHOD FOR CHANGING THE REFRACTIVE POWER OF AN EYE ALLERGAN SALES, INC. (US) 1998-07-09 WO claimed
WO-1998015568-A2 NITRATE ESTERS OF CORTICOID COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF NICOX S.A. (FR) 1998-04-16 WO claimed
US-5624893-A Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation ALCON LABORATORIES, INC. (US) 1997-04-29 US claimed
US-5525349-A BEFORE AND AFTER EYE SURGERY TREATMENT APPLYING A STEROID ANTIINFLAMMATORY AGENT, MICROBIOCIDES ALCON LABORATORIES, INC. (US) 1996-06-11 US claimed
US-5401509-A Pharmaceutical compositions and methods of treatment of the cornea in conjunction with laser irradiation ALCON LABORATORIES, INC. (US) 1995-03-28 US claimed
WO-1993017664-A1 COMBINATIONS OF CELLULOSIC POLYMERS AND CARBOXY VINYL POLYMERS AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS ALCON LABORATORIES, INC. (US) 1993-09-16 WO claimed
WO-1990001933-A1 COMBINATION OF QUINOLONE ANTIBIOTICS AND STEROIDS FOR TOPICAL OPHTHALMIC USE ALCON LABORATORIES, INC. (US) 1990-03-08 WO claimed